Sight Sciences, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Sight Sciences, Inc. - overview
Established
2011
Location
Menlo Park, CA, US
Primary Industry
Medical Devices & Equipment
About
Based in California, US, and founded in 2011 by co-founders David Badawi and Paul Badawi, Sight Sciences, Inc. operates as a medical device company that develops eye treatment devices for glaucoma. The company has 169 employees as of June 2021. Sight Sciences has raised a total of USD 108.
7 million in funding. It is backed by Allegro Investment Fund, KCK Group, MidCap Financial, and D1 Capital Partners. The company released its IPO in July 2021 and is listed on Nasdaq under the ticker symbol SGHT. The company has 184 employees.
The company develops engineered products to target glaucoma and dry eye disease through minimally invasive or non-invasive approaches. The company's OMNI surgical system is a minimally invasive glaucoma surgery (MIGS) device indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma (POAG) which causes irreversible blindness. Sight Sciences provides a TearCare® System which is a wearable, office-based thermal eyelid technology that enables the controlled application of localized heat to the eyelids to relieve dry eye disease. Sight Sciences generated USD 30 million in revenue from March 2020 to March 2021.
Current Investors
Hicks Equity Partners, Scientific Health Development, Allegro Investment Fund
Primary Industry
Medical Devices & Equipment
Sub Industries
Surgical Devices, Therapeutic Devices
Website
www.sightsciences.com
Verticals
Manufacturing, Wearables & Quantified Self
Company Stage
Mature
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.